malondialdehyde has been researched along with Jejunal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, XF; Lian, HF; Liu, CX; Liu, Z; Niu, Q; Shi, N; Wang, AL; Wang, J | 1 |
| Burcu, B; Kanter, M; Karabacak, R; Orhon, ZN; Yarali, O | 1 |
| Cao, J; Gao, L; Liang, F; Liu, DD; Sun, BW; Wang, X | 1 |
3 other study(ies) available for malondialdehyde and Jejunal Diseases
| Article | Year |
|---|---|
Glutamine ameliorates intestinal ischemia-reperfusion Injury in rats by activating the Nrf2/Are signaling pathway.
Topics: Animals; Antioxidant Response Elements; Binding Sites; Caspase 3; Cytoprotection; Disease Models, Animal; Gene Expression Regulation; Glutamine; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Jejunal Diseases; Jejunum; Male; Malondialdehyde; NF-E2-Related Factor 2; Oxidative Stress; Permeability; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Reperfusion Injury; Signal Transduction; Superoxide Dismutase | 2015 |
Protective Effects of Vitamin E on Methotrexate-Induced Jejunal Mucosal Damage in Rats.
Topics: Animals; Antioxidants; Biomarkers; Cytoprotection; Disease Models, Animal; Gastrointestinal Hemorrhage; Glutathione Peroxidase; Intestinal Mucosa; Jejunal Diseases; Jejunum; Male; Malondialdehyde; Methotrexate; Necrosis; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Rats, Wistar; Superoxide Dismutase; Time Factors; Vitamin E | 2016 |
Exogenous carbon monoxide attenuates inflammatory responses in the small intestine of septic mice.
Topics: Animals; Caco-2 Cells; Carbon Monoxide; Disease Models, Animal; Enteritis; Humans; Ileitis; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-8; Intestine, Small; Jejunal Diseases; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Organometallic Compounds; Peroxidase; Sepsis; Time Factors; Tumor Necrosis Factor-alpha | 2012 |